Conference abstractPublished 18 Jul 2018
Discovery of highly potent anti-HCV with new core scaffolds and new conformational aspects
German University in Cairo, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
NS5A is a dimeric protein and an interesting target to inhibit the replication of HCV. Reported here are two series of symmetric molecules with the scaffolds of 4, 4â??-(buta-1,3-diyne- 1,4-diyl) dianiline core- and 3, 3â??-(buta-1,3-diyne- 1,4-diyl) dianiline core, connected to a L/D-proline moiety and capped with the methyl, ethyl, butyl, isobutyl and benzyl carbamate of L/D-valine, L/D-leucine and L-isoleucine amino acids. The compounds showed inhibitory effect on the replication of HCV genotype 1b in vitro with EC50s in the low picomolar range and SI50s of several orders of magnitude. Also, some of the compounds showed pan-genotypic activitiy. Higher activities were associated with compounds showing curving of the core scaffolds that leads to better fit and interaction with the desired target.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ashraf H Abadi”
